Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA approval
Pharma
Rhythm's Imcivree bags FDA nod for brain-damage related obesity
The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired hypothalamic obesity.
Zoey Becker
Mar 20, 2026 11:05am
Novo scores FDA nod for Wegovy HD, plans April launch
Mar 19, 2026 2:11pm
After Alfasigma licensing deal, Lynavoy picks up FDA nod
Mar 19, 2026 10:55am
FDA approves J&J, Protagonist's blockbuster-to-be psoriasis pill
Mar 18, 2026 11:33am
FDA approves Ascendis' achondroplasia treatment Yuviwel
Mar 2, 2026 9:25am
4 years after rejection, FDA signs off on Immedica's Loargys
Feb 24, 2026 8:55am
